New Call for Abstracts and Registration [International Conference on AIDS (8th: 1992: Amsterdam, Netherlands)]

671 hemophilus infections
672 Henoch-Schonlein purpura
673 heparin
674 hepatitis, B
675 hepatitis, non-A, non-B
676 hepatitis, other
677 heroin
678 herpes viruses
679 heterosexual, hemophilia
680 heterosexual, HIV-2
681 heterosexual, prevalence
682 heterosexual, prevention
683 heterosexual, prognosis
684 heterosexual, progression
685 heterosexual, SEE sexual
behavior
686 heterosexual, SEE transmission
687 heterosexual, other
688 HGP-30
689 high risk groups, combined SEE
also gay men, hemophilia IVDU,
geographical regions
690 hispanic issues
691 histamine
692 histopathology
693 histoplasmosis
694 history
695 HIV antigenemia
696 HIV antigen, assay
697 HIV, AZT
698 HIV, biopsy
699 HIV, brain
700 HIV, children
701 HIV, core protein, SEE gene
products
702 HIV, flow cytometry, SEE
gp 120
703 HIV, immune complexes
704 HIV, infectivity
705 HIV, lung
706 HIV, monitor
707 HIV, pregnancy
708 HIV, prognosis
709 HIV, seroconversion
710 HIV, standardization
711 HIV, other
712 HIV-immunogen
713 HIV-Iscom
714 HIV negative AIDS-related
complex
715 HIV-specific active immunotherapy (HSAI)
716 HIV-2, association with other
HIV/HTLV
717 HIV-2, disease
718 HIV-2, natural history
719 HIV-2, serologic tests
720 HIV-2, seroprevalence
721 HIV-2, transmission
722 HIV-2, other

726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755

HOE/BAY 946
home care
homelessness
homosexuals, SEE gay men,
lesbians
hormones
hospice care
hospital cost, SEE cost
hospitals
hot-line
HPA-23
HSV-2, SEE herpes viruses
HTLV-I, disease
HTLV-I, serologic tests
HTLV-I, seroprevalence
HTLV-I, other
HTLV-II
human herpes virus 6 (HHV-6)
human papilloma virus (HPV)
human rights
hybridization
hydrocotil asiatica
hydroxyurea
hypericin
hypertriglyceridemia
hyponatremia
IEC (information-educationcommunication)
IL-i
IL-2
IL-2 receptor
IL-2 receptor, soluble

783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842

843
844

incubation time
infection, primary
infectivity, activation
influenza
information systems
insemination
insulin
insurance
integrated care model
integration
intensive care unit (ICU)
interferon, acid labile
interferons, alfa
interferons, beta
interferons, gamma
interferons, other
intestine
intravenous drug users, SEE
IVDU
iodo-deoxyuridine (IUDR)
iscom, SEE HIV-iscom
isolate, African
isolate, Brazil
isolate, Cameroon
isolate, Cuba
isolate, early
isolate, Gabon
isolate, HIV-2
isolate, India
isolate, SIV
isolate, South American
isolate, standard
isolate, other
isolation, cerebrospinal fluid
isolation, plasma
isolation, sweat
isolation, urine
isolation, other
isospora belli
isoprinosine
itraconazole
IVDU (intravenous drug users)
IVDU, behavior
IVDU, geographical
IVDU, HIV-2
IVDU, HTLV-1I
IVDU, immunology
IVDU, methadone
IVDU, needle-syringe exchange
IVDU, pregnancy
IVDU, prevalence
IVDU, prevention
IVDU, prognosis
IVDU, progression
IVDU, psychological
IVDU, SEE sexual hehavior
IVDU, suhgroups
IVDU, support
IVDU, symptoms
IVDU, testing
IVDU, treatment

IVDU, other
justice

845 KAB (knowledge-attitudebehavior)
846 Kaplan-Meier analysis
847 Kaposi's sarcoma, children
848 Kaposi's sarcoma, epidemiology
849 Kaposi's sarcoma, growth
factors
850 Kaposi's sarcoma,
histopathology
851 Kaposi's sarcoma, immunology
852 Kaposi's sarcoma, oncogenes
853 Kaposi's sarcoma, survival
854 Kaposi's sarcoma, tissue culture
855 Kaposi's sarcoma, treatment
856 Kaposi's sarcoma, other
857 ketoconazole
858 kidney
859 knowledge, SEE survey
860 Kuppfer cells
861 laboratory tests, routine
862 laboratory tests, other
863 L-acetyl carnitine
864 lactate dehydrogenase
865 Langerhans cells
866 laser therapy
867 latency, cell line
868 latency, regulation
869 latency, reservoir
870 latency, other
871 law
872 LDH (lactate dehydrogenase)
873 lectins
874 legal assistance
875 legionella micdadei
876 legislation
877 lentinan
878 leishmaniasis
879 leprosy
880 lesbian
881 leucovorin
882 leukemia
883 LF1695
884 LFA-1
885 LIP
886 lipids
887 lipophilicity
888 liposomes
889 literature review
890 litigation
891 liver
892 LOS (length of stay)
893 lung, symptoms
894 lung, cytomegalovirus, SEE
cytomegalovirus
895 lung, diagnosis SEE also
penemocystis, pneumonitis
896 lymph nodes
897 lymph nodes, histopathology
898 lymphocytes (see also CD4,
CD8(
899 lymphocytes, SEE CD4, CD8

900 lymphoma, non-Hodgkin's
901 lymphoma, Hodgkin's

756 IL-6
757 immigration policy, SEE
public policy
758 immune complexes
759 immune thrombocytopenia
(ITP)

760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782

immunization
immunoadhesion
immunoassay
immunoglobins, general
immunoglobulin
immunoglobulins, IgA
immunoglobulins, IgD
immunoglobulins, IgE
immunoglobulins, IgG subclass
immunoglobulins, IgM
immunomodulation
immunopathology
immunosuppression, mechanism
immunosuppression, serum
immunosuppression, other
immunotherapy
immunotoxin
implantable infusion ports
(PAC)
IMREG-1
IMREG-2
imuthiol
inactivation
incidence

723
724
725

HLA
HLA, expression
HMO (health maintenance
organization)

xxiii